NO924760D0 - N-(3-(2-(1h-imidazol-1-yl) etoksy) (2-tienyl)-2-pyrimidinamin og farmakologisk akseptable salter derav - Google Patents

N-(3-(2-(1h-imidazol-1-yl) etoksy) (2-tienyl)-2-pyrimidinamin og farmakologisk akseptable salter derav

Info

Publication number
NO924760D0
NO924760D0 NO924760A NO924760A NO924760D0 NO 924760 D0 NO924760 D0 NO 924760D0 NO 924760 A NO924760 A NO 924760A NO 924760 A NO924760 A NO 924760A NO 924760 D0 NO924760 D0 NO 924760D0
Authority
NO
Norway
Prior art keywords
pyrimidinamine
imidazol
ethoxy
acceptable salts
tienyl
Prior art date
Application number
NO924760A
Other languages
English (en)
Other versions
NO924760L (no
NO301476B1 (no
Inventor
Rolf Paul
Robert Gerard Kelly
Lawrence W Torley
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of NO924760D0 publication Critical patent/NO924760D0/no
Publication of NO924760L publication Critical patent/NO924760L/no
Publication of NO301476B1 publication Critical patent/NO301476B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO924760A 1991-12-31 1992-12-09 N-£3-£2-(1H-imidazol-1-yl)etoksy|-4-(2-tienyl)-2-pyrimidinamin og farmakologisk akseptable salter derav NO301476B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/816,335 US5162328A (en) 1991-12-31 1991-12-31 N-[3-[2-(1H-imidazol-1-yl)ethoxy]phenyl]-4-(2-thienyl)-2-pyrimidinamine and pharmacologically acceptable salts

Publications (3)

Publication Number Publication Date
NO924760D0 true NO924760D0 (no) 1992-12-09
NO924760L NO924760L (no) 1993-07-01
NO301476B1 NO301476B1 (no) 1997-11-03

Family

ID=25220310

Family Applications (1)

Application Number Title Priority Date Filing Date
NO924760A NO301476B1 (no) 1991-12-31 1992-12-09 N-£3-£2-(1H-imidazol-1-yl)etoksy|-4-(2-tienyl)-2-pyrimidinamin og farmakologisk akseptable salter derav

Country Status (16)

Country Link
US (1) US5162328A (no)
EP (1) EP0549880B1 (no)
JP (1) JPH05271227A (no)
KR (1) KR930012761A (no)
AT (1) ATE171178T1 (no)
AU (1) AU651539B2 (no)
CA (1) CA2086357A1 (no)
DE (1) DE69227015T2 (no)
DK (1) DK0549880T3 (no)
ES (1) ES2121809T3 (no)
FI (1) FI925951A (no)
HU (1) HUT66943A (no)
NO (1) NO301476B1 (no)
NZ (1) NZ245513A (no)
SG (1) SG47556A1 (no)
ZA (1) ZA9210120B (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2628474A1 (en) * 2005-11-03 2007-05-10 Sgx Pharmaceuticals, Inc. Pyrimidinyl-thiophene kinase modulators

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4788195A (en) * 1986-01-13 1988-11-29 American Cyanamid Company 4,5,6-substituted-N-(substituted-phenyl)-2-pyrimidinamines
ATE135699T1 (de) * 1986-01-13 1996-04-15 American Cyanamid Co 4,5,6-substituierte 2-pyrimidinamine

Also Published As

Publication number Publication date
EP0549880A1 (en) 1993-07-07
FI925951A (fi) 1993-07-01
JPH05271227A (ja) 1993-10-19
ATE171178T1 (de) 1998-10-15
FI925951A0 (fi) 1992-12-30
AU3046292A (en) 1993-07-08
CA2086357A1 (en) 1993-07-01
HU9204172D0 (en) 1993-04-28
ZA9210120B (en) 1994-04-12
US5162328A (en) 1992-11-10
KR930012761A (ko) 1993-07-21
HUT66943A (en) 1995-01-30
SG47556A1 (en) 1998-04-17
NO924760L (no) 1993-07-01
NZ245513A (en) 1994-07-26
AU651539B2 (en) 1994-07-21
NO301476B1 (no) 1997-11-03
DK0549880T3 (da) 1999-06-14
ES2121809T3 (es) 1998-12-16
EP0549880B1 (en) 1998-09-16
DE69227015D1 (de) 1998-10-22
DE69227015T2 (de) 1999-03-25

Similar Documents

Publication Publication Date Title
UY26480A1 (es) Inhibidores de n - (5 - ( 5 - alquil - 2 - oxazolil) metil ) tio) - 2 - tiazolil) - carboxamida de cinasas dependientes de ciclina
DK0957099T3 (da) Heterocykliske carboxamider
NO933093D0 (no) Monohydrat av 5-(2-(4-(1,2-benzisotiazol-3-yl)-1-piperazinyl)-etyl)-6-klor-1,3-dihydro-2h-indol-2-on hydroklorid
ATE96783T1 (de) Pyrrolidin-derivate.
NO910270L (no) N-fenylalkyl-substituerte alfa-aminokarboksamidderivater og deres fremstilling.
KR950016738A (ko) 알쯔하이머 질병의 억제 방법
DE69230803D1 (de) 5-(hetero- oder carbocyclylamino)-indol derivate, deren herstellung und deren verwendung als 5-ht1 agonisten
DK0646115T3 (da) Heterocykliske/cykliske aminderivater
CY1111191T1 (el) Θεραπευτικος παραγοντας για την διαταραχη του κερατο-επιπεφυκοτα
SE9600406D0 (sv) Novel coompounds
NO964950L (no) Krystallinsk hydroklorid av (R)-(-)-2-{N-£4-(1,1-dioksido-3-okso-2,3-dihydro-benziso-tiazol-2-yl)-butyl|-aminometyl}-kroman
MX9304215A (es) Nuevos derivados piperidinicos del bencimidazol.
DE59309819D1 (de) Verwendung von 2-(N-(2-Aminoethyl)amino)-essigsäure-derivaten zur Behandlung von Erkrankungen, die durch die nichtenzymatische Glykosylierung bedingt sind
TR200001872A3 (tr) 4-[5-(4-Metilfenil-3-(triflorometil)-1H-pirazol-1-il] benzensulfonamit' in yeni kristal biçimi "Biçim I" ve bu ürünün üretilmesine iliskin yöntem.
UY26481A1 (es) Inhibidores de n - (5 - ( ( (5 - alquil - 2 - oxazolil) metil) tio) - 2 - tiazolil) - carboxamida de cinasas dependientes de ciclina.
DE69323667D1 (de) 4-substituierte 1,2,4-Triazolderivate
DK0474580T3 (da) Anvendelse af 1-(3-dimethylamino)propyl)-1-phenylphthalener til behandling af cerebrovaskulære sygdomme
PT790236E (pt) Pro-farmacos de 5-(2-(4-(1,2-benzisotiazol-3-il)-1-piperazinil)-etil-6-cloro-1,3-di-hidro-2h-indol-2-ona
NO924760D0 (no) N-(3-(2-(1h-imidazol-1-yl) etoksy) (2-tienyl)-2-pyrimidinamin og farmakologisk akseptable salter derav
BR0201569A (pt) 4-(2-piridil) piperizinas possuindo uma atividade agonista do receptor 5ht7
NO964269L (no) 2,3-dihydroksypropyl 2-(1-oksoalkyl)amino-2-deoksogluco-pyranosider, deres fremstilling og anvendelse
ES2081810T3 (es) Derivados de 4-fenil-4-(n-(2-fluorofenil)amido)-piperidina.
EP0317259A3 (en) Heterocyclic insecticides
NZ336585A (en) 2,6-dimethyl-4-(3-nitro-phenyl)-5-methoxycarbonyl-1,4-dihydropyridine-3-carboxylate derivatives substituted by N-[5-(1H-2-pyrrolyl)-5-oxopentyl] or [4-(2-thienoyl or 2,4,6-trimethoxybenzoyl)-butyl]-pyrrolid-3-ine or piperid-3-ine
FI972528A0 (fi) Menetelmä N-(4-(5-(syklopentyylioksikarbonyyli)amino-1-metyyli-indol-3-yyli-metyyli)-3-metoksibentsoyyli)-2-metyylibentseenisulfonamidin fysikaalisen muodon valmistamiseksi